News
MuScan for Microplastics detection, quantification and identification
In recent years we have developed an innovative application for the rapid diagnosis of microplastics. This solution will play a crucial role in combating microplastic pollution by enabling the quick and precise on-site identification of microplastic particles. Thanks to funding from the KPF program (Interreg 6a), we were able to further advance the image analysis software in collaboration with our German partner ISIS-IC GmbH.
The handling protocol and software are presented in the following English link, German link and Dutch link.
The project ISeeMicroplastics was made possible by the Interreg Program Germany-The Nerherlands with its prgram partners and cofinanced by the European Union (EU).
JANUARY 2023: MOVED TO A NEW LOCATION
After 11 years at Business Partner Building in Wageningen, Innosieve Diagnostics BV has moved to a new location! This new location at Costerweg 1A in Wageningen offers a better fit for the laboratory and office needs of Innosieve.
OPTION: LEASE YOUR MUSCAN!
We are proud our Next Generation Rapid Microbial Method, the Muscan, has been validated for bioburden testing, including GMP software that is fully CFR21 Part11 supportive. To offer an easy access to a RMM like the MuScan, we provide now the option of lease. Low monthly costs, maximum gain!
MUSCAN VS COMPENDIAL
After extensive studies the Sieve-ID(TM) Total Viable Count kit with MuScan(TM) analysis was found to be at least equal to the compendial method according to USP[1223] and Ph.Eur 5.1.6 for the direct detection and enumeration of viable microbes. The comparison of a growth-based method with a direct method has given Innosieve much insight in best method validation approaches.
CFR COMPLIANCY SOFTWARE
We are proud to announce that the MuScan(TM) software meets 21 CFR part 11 compliancy. The software has a main focus on full digital processing and handling for optimal user friendliness while safeguarding your process and data.
LAB FACILITIES EXPANDED
To align with the growth of Innosieve Diagnostics BV the contract with Kadans Vastgoed BV was extended. Innosieve Diagnostics BV has now doubled its space in housing to meet development and production needs.
ACQUISITION OF LUMIBYTE BV
Innosieve Diagnostics BV has acquired the activities and intellectual properties of Lumibyte BV, subsidiary of Sioux BV. By acquisition of Lumibyte BV, Innosieve Diagnostics BV has now full ownership of all intellectual property of the MuScan(TM) device.
